Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Reports on cancer gene therapy findings from University of Alabama, Gene Therapy Center provide new insights
July 8th, 2008
New investigation results, 'Development of an optimized conditionally replicative adenoviral agent for ovarian cancer,' are detailed in a study published in International Journal of Oncology. According to a study from the United States, "Human ovarian cancer is a highly lethal malignant neoplasm in woman with no effective treatment if conventional chemotherapy fails. In this regard, conditionally replicative adenoviruses (CRAds) represent a promising new modality for the treatment of cancer." "A key contribution to the development of CRAds was the introduction of tumor-selective viral replication to restrict amplification to the neoplastic cell population. Under...
Source: Cancer Weekly (2008-07-08)
|
